# The Effect of Intranasal Insulin on Motor and Non-motor Symptoms in Parkinson's Disease Patients

> **NCT04687878** · PHASE2 · COMPLETED · sponsor: **dr.dargahi** · enrollment: 28 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** Insulin
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT04687878
- **Lead sponsor:** dr.dargahi
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-01
- **Primary completion:** 2022-06-20
- **Final completion:** 2023-09-20
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2024-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04687878

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04687878, "The Effect of Intranasal Insulin on Motor and Non-motor Symptoms in Parkinson's Disease Patients". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04687878. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*